S1PR1 inhibitor

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all S1PR1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting S1PR1.

Targets

Phase 3 pipeline (1)

OPC-262 · Kyowa Kirin Co., Ltd. · Immunology
OPC-262 is a selective and potent inhibitor of the sphingosine-1-phosphate receptor 1 (S1PR1).

Phase 2 pipeline (1)

ABBV-552 · AbbVie · Autoimmune diseases
ABBV-552 is a small molecule inhibitor of the sphingosine-1-phosphate receptor 1 (S1PR1).